A once-weekly semaglutide injection goes under the skin of your stomach, thigh or upper arm, once a week on the same day. Here is how to inject semaglutide from a compounded vial the way FDA and NIH guidance describe it, with your dose always set by your clinician.
Social media calls berberine "nature's Ozempic." It is a plant compound sold as a supplement, and it does not work like semaglutide. Here is what the evidence shows for weight and blood sugar.
Both are weekly GLP-1 pens for type 2 diabetes, from different makers and with different molecules. One trial put them head to head. Here is what it found, and what it did not test.
They share an active ingredient and very little else: regulatory status, trial evidence, delivery and price all differ. Here is the honest comparison, and how to decide which one fits your situation.
One is a decades-old stimulant pill meant for a few weeks. The other is a weekly GLP-1 built for long-term treatment. Here is how they compare on results, safety, duration and cost.
One is a low-cost diabetes pill with decades of use. The other is a GLP-1 with an approved weight-loss version and a much larger effect on the scale. Here is how they compare, and why many people take both.
One is a triple-hormone drug with striking phase 3 results and no approval date. The other is an approved GLP-1 with years of label data behind it. Here is the honest comparison.
Semaglutide constipation is common: in the Wegovy weight-loss trials it affected 24% of people on the medication, against 11% on placebo. Most of it responds to fiber, fluids and a routine. Here is the plan Arbor's clinicians walk patients through, and the few signs that mean you should not wait it out.
"Ozempic face" is not a side effect listed in the Ozempic or Wegovy prescribing information. It is a nickname for the hollow, looser look that can follow fast, large weight loss, and the habits that lower the odds are the same ones Arbor's clinicians build into every GLP-1 program.
Switching is one of the most common changes Arbor's clinicians manage, and it does not mean starting over. Here is the standard approach, what the first weeks usually feel like, and how to keep your routine steady while the new medication builds.
Semaglutide has reshaped the landscape of medical weight loss. Clinical trials demonstrate an average body weight reduction of 14.9% over 68 weeks, and many patients experience rapid, visible results within the first few months of treatment.